复杂型轻度创伤性脑损伤患者抗癫痫药物使用的国际调查:纽约神经创伤联盟研究
该国际调查通过专业组织邮件列表和社交媒体招募92名有复杂型轻度创伤性脑损伤(cmTBI)管理经验的提供者,评估影响抗癫痫药物(ASM)预防使用的因素。结果显示ASM使用差异显著:30%报告不使用/不频繁使用,42%报告频繁使用,且与提供者或机构特征无关;急性继发性癫痫发作或特定阳性神经影像学表现普遍增加ASM使用,而高龄和合并神经精神疾病普遍降低使用。作者认为需前瞻性对照研究以指导标准化指南制定。
要点
- 92名提供者完成调查,30%报告不使用/不频繁使用ASM,42%报告频繁使用,使用模式与提供者或机构特征无关。
- 急性继发性癫痫发作或特定阳性神经影像学表现普遍增加ASM使用,代表共识。
- 作者建议对高龄患者和合并神经精神疾病患者谨慎使用ASM。
核心结论
- 本研究首次基于多学科多中心提供者实践,描述影响cmTBI后ASM预防临床决策的因素。
- 需要前瞻性对照研究以指导标准化指南制定。
研究设计与样本
- 通过专业组织邮件列表和社交媒体平台招募国际多学科队列,使用问卷评估影响cmTBI后ASM预防的个体、机构和卫生系统层面因素。
主要发现
- 92名有cmTBI管理经验的提供者完成调查。
- ASM使用差异显著:30%受访者报告不使用/不频繁使用,42%报告频繁使用;这些倾向与提供者或机构特征无关。
- 某些情况普遍增加或降低ASM使用可能性并代表共识。
关键数值与推荐
- 急性继发性癫痫发作或特定阳性神经影像学表现的患者中ASM常用。
- 高龄患者和合并神经精神疾病患者中ASM使用普遍降低。
临床怎么用
- 作者建议对高龄患者和合并神经精神疾病患者谨慎使用ASM。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seizures and epilepsy after traumatic brain injury (TBI) negatively affect quality of life and longevity. Antiseizure medication (ASM) prophylaxis after severe TBI is associated with improved outcomes; these medications are rarely used in mild TBI. However, a paucity of research is available to inform ASM use in complicated mild TBI (cmTBI) and no empirically based clinical care guidelines for ASM use in cmTBI exist. We aim to identify seizure prevention and management strategies used by clinicians experienced in treating patients with cmTBI to characterize standard care and inform a systematic approach to clinical decision making regarding ASM prophylaxis. METHODS: We recruited a multidisciplinary international cohort through professional organizational listservs and social media platforms. Our questionnaire assessed factors influencing ASM prophylaxis after cmTBI at the individual, institutional, and health system-wide levels. RESULTS: Ninety-two providers with experience managing cmTBI completed the survey. We found a striking diversity of ASM use in cmTBI, with 30% of respondents reporting no/infrequent use and 42% reporting frequent use; these tendencies did not differ by provider or institutional characteristics. Certain conditions universally increased or decreased the likelihood of ASM use and represent consensus. Based on survey results, ASMs are commonly used in patients with cmTBI who experience acute secondary seizure or select positive neuroimaging findings; we advise caution in elderly patients and those with concomitant neuropsychiatric illness. CONCLUSIONS: This study is the first to characterize factors influencing clinical decision making in ASM prophylaxis after cmTBI based on multidisciplinary multicenter provider practices. Prospective controlled studies are necessary to inform standardized guideline development.
引用
- Hickman ZL, Spielman LA, Barthélemy EJ, et al. International Survey of Antiseizure Medication Use in Patients with Complicated Mild Traumatic Brain Injury: A New York Neurotrauma Consortium Study. World Neurosurg. 2022. PMID: 36191888. doi:10.1016/j.wneu.2022.09.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。